sur VINPAI (isin : FR001400AXT1)
Camlin Fine Sciences Adjusts Vinpai Takeover Plans
Camlin Fine Sciences Limited (CFSL) has announced a delay in filing its simplified cash tender offer for Vinpai shares. Originally planned for February 2026, the filing is now postponed till early May 2026. The delay allows Vinpai's 2025 financial results to be included in the offer documentation.
CFSL aims to keep Vinpai listed on Euronext Growth Paris, opting against a squeeze-out, as part of a broader European restructuring strategy. Maintaining the listing will help Vinpai access financial markets for debt restructuring and future project financing.
Vinpai is recognized for its functional ingredients, impacting the food and cosmetics sectors. Camlin holds 78.68% of Vinpai's share capital, following a majority acquisition completed in November 2025. The tender offer price remains €3.60 per share.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de VINPAI